13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 26 holding rows worth $1,870,521,000.
- Accession
- 0001144204-18-059977
- Filer
- CIK 1346824
- Filed
- 2018-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 26 entries on the cover page, a total value of $1,870,521,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,870,521,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,512,049 | $375,602,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,240,536 | $300,484,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 2,689,444 | $126,888,000 | thousands by filing date | |
| ENDOCYTE INC | 29269A102 | COM | 6,196,143 | $110,043,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 1,878,768 | $93,187,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 3,451,859 | $91,647,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 9,234,692 | $70,461,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 3,851,808 | $69,679,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 1,967,848 | $67,537,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 3,119,778 | $64,985,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,933,489 | $60,025,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 1,950,332 | $56,891,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 3,138,412 | $52,945,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 350,933 | $49,569,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,701,017 | $48,734,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 8,198,337 | $45,911,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,558,357 | $40,985,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,441,070 | $31,862,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 2,162,671 | $21,583,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 2,113,236 | $20,858,000 | thousands by filing date | |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 3,030,303 | $19,000,000 | thousands by filing date | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 2,857,143 | $16,771,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 900,000 | $16,002,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,121,153 | $12,613,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 253,547 | $3,651,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,337,462 | $2,608,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-18-059977 | this filing | 2018-11-14 | acceptance time not in the bulk data set |